Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
Boston Scientific Corp. is recalling guidewire components for its Rotablator Rotational Atherectomy System used to open narrowed arteries and improve blood flow to the heart by cutting plaque from the artery wall, after receiving reports of the core wires cracking and separating from the rest of the system, causing serious adverse events including one death. The recall involves the RotaWire Elite Guidewire and wireClip Torquer Guidewire, components of the Rotablator Rotational Atherectomy System. Serious injuries reported include tamponade (blood in the sac around the heart causing decreased heart function), myocardial infraction (heart attack), and migration of wire fragments elsewhere in ... Read More
When Charlie Sheen announced last month on national TV that he was infected with HIV, the actor admitted that he continues to have sex despite his diagnosis and that he is confident he hadn’t passed the virus on to others. That’s because Sheen’s doctor, Dr. Robert Huizenga, has prescribed to several of the actor’s sexual partners a once-daily pill that helps prevent them from catching the virus. The pill is called pre-exposure prophylaxis, or PreEP, and is sold under the brand name Truvada. Gilead Sciences first obtained FDA approval for the drug in 2004 for people with HIV. It is ... Read More
C.R. Bard was slapped with a $3.6 million verdict in the first lawsuit to go to trial involving the medical device manufacturer’s allegedly defective transvaginal mesh. The ruling comes just months after the company agreed to settle thousands of other lawsuits from women who claim to have been injured by the transvagainal mesh. The jury had awarded the plaintiff in the case $5.5 million in damages, but the court slashed the award to $3.6 million after finding some fault with the doctor who had implanted the plaintiff with the company’s Avaulta transvaginal mesh. Transvaginal mesh, also known as bladder sling, ... Read More
The Food and Drug Administration (FDA) has expanded the use of the blood thinner Pradaxa, known chemically as dabigatran etexilate mesylate, for the prevention of blood clots in patients who have recently undergone hip replacement surgery. This is the fourth indication for Pradaxa since the drug was approved in 2010. Pradaxa, manufactured by Boehringer Ingelheim, was initially approved for the prevention of strokes in patients with a common heart rhythm abnormality called atrial fibrillation. It was the first drug in a new class of blood thinners known as factor Xa inhibitors. Since then, the FDA has approved three other blood ... Read More
The Food and Drug Administration (FDA) says it is reviewing data on adverse events associated with the permanent birth control method Essure and will publish its recommendations in late February. Essure, made by Bayer Healthcare, is the only FDA-approved nonsurgical permanent contraceptive. It consists of two small, nickel alloy coils, which are implanted through the vagina into the fallopian tubes. The implants work with the body to create a scar tissue barrier that prevents sperm from reaching the egg, thus preventing pregnancy. The device has been on the market since 2002, but reports of Essure side effects have increased in ... Read More
Type 2 diabetics at high risk for cardiovascular disease (CVD) often become intolerant to cholesterol-lowering statins, new research has found. Statins are among the most prescribed drugs in the world. They are designed to lower cholesterol levels in order to prevent heart attacks, strokes and cardiovascular-related death. Type 2 diabetes is a chronic disease that is often associated with being overweight and leading a sedentary lifestyle. As a result, many diabetics also have high cholesterol. Researchers from Amgen Inc. set out to evaluate how cholesterol therapies, such as the widely prescribed Lipitor, affected adults with type 2 diabetes. They used ... Read More
Carol Wiltshire and her husband, Jeff, of Illinois, are suing the manufacturers of a warming blanket used during Carol’s knee replacement surgery, claiming the device was defective and cause her to develop a surgical site infection deep in her knee joint. The couple’s lawsuit names 3M Corporation and its subsidiary Arizant Healthcare, makers of the Bair Hugger, a warming blanket used most often during surgeries such as hip and knee replacements. The lawsuit also names OSF Healthcare, Dr. Bruce Vest, and Orthopedic & Sports medicine for failing to use the skill and appropriate care required for her recovery. A growing number ... Read More
U.S. District Judge Kathryn Vratil of Kansas has appointed the first plaintiffs steering committee in a multidistrict litigation (MDL) in which the majority of the members is female. The lawsuits making up the MDL allege that Johnson & Johnson’s unit Ethicon Inc.’s power morcellator device used to perform hysterectomies and uterine fibroid removals caused the spread of undiagnosed uterine cancer, worsening the odds of survival. Last year, Vratil spoke at a conference at the Duke Law School’s Center for Judicial Studies about the lack of women in leadership on MDLs historically. With an issue that affects women, such as cancer ... Read More
Novo Nordisk has made great strides to expand the indication of its type 2 diabetes drug Victoza by gaining approval for a high-dose version as a weight loss treatment, marketed as Saxenda. The company is also testing the drug as a treatment for nonalcoholic fatty liver disease. But a new study found the drug ineffective in patients with advanced heart failure. Heart failure is a chronic condition in which the heart does not pump enough blood through the body. About 5 million Americans have heart failure. The study sought to find whether Victoza, known chemically as liraglutide, could correct defects in ... Read More
A Pennsylvania congressman has made good on his promise to introduce legislation to ban the permanent birth control implant Essure in response to complaints from thousands of women who say they have been harmed by the device. U.S. Rep. Mike Fitzpatrick introduced the bipartisan bill aimed at revoking the Food and Drug Administration’s (FDA) premarket approval status of Essure and requiring the manufacturer, Bayer Healthcare, to pull the device from the market. Essure was approved by the FDA in 2002, and remains the only FDA-approved non-surgical permanent birth control method available in the United States. Essure is a flexible, nickel-titanium ... Read More